Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-18

Clinical Trial Update: Ubenimex in Adult Patients With Lymphedema of The Lower Limb (ULTRA) [Phase 2]

View source ↗

Summary

Phase 2 trial update for ubenimex in adult lower-limb lymphedema (ULTRA) with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ubenimex (ubenimex)

Snippet

Sponsor: Eiger BioPharmaceuticals | Conditions: Lymphedema | Phase 2 | Status: COMPLETED | Results posted: 2023-01-18